-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Oncology Institute, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to Q3 2025.
- Oncology Institute, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$8.45M, a 274% decline year-over-year.
- Oncology Institute, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$25.3M, a 258% decline year-over-year.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2024 was -$4.55M, a 25.3% increase from 2023.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2023 was -$6.09M, a 107% decline from 2022.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2022 was $81.9M, a 139% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)